{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T12:12:43Z","timestamp":1777464763351,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1080\/00313020400011268","type":"journal-article","created":{"date-parts":[[2005,2,8]],"date-time":"2005-02-08T20:37:48Z","timestamp":1107895068000},"page":"561-565","source":"Crossref","is-referenced-by-count":15,"title":["Histological expression of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in human primary melanoma"],"prefix":"10.1016","volume":"36","author":[{"given":"Luc P.","family":"Bron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Scolyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Hersey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1080\/00313020400011268_bib0010","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0952-7915(98)80224-0","article-title":"TRAIL: a molecule with multiple receptors and control mechanism","volume":"10","author":"Griffith","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"10.1080\/00313020400011268_bib0015","doi-asserted-by":"crossref","first-page":"12687","DOI":"10.1074\/jbc.271.22.12687","article-title":"Induction of apoptosis by Apo-2 ligand, a new member of the tumour necrosis factor cytokine family","volume":"271","author":"Pitti","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1080\/00313020400011268_bib0020","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","article-title":"Identification and characterization of a new member of the TNF family that induces apoptosis","volume":"3","author":"Wiley","year":"1995","journal-title":"Immunity"},{"key":"10.1080\/00313020400011268_bib0025","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.4049\/jimmunol.161.6.2833","article-title":"Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells","volume":"161","author":"Griffith","year":"1998","journal-title":"J Immunol"},{"key":"10.1080\/00313020400011268_bib0030","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.4049\/jimmunol.162.10.6053","article-title":"TRAIL (Apo2L) and TRAIL receptors in human placentas: implication for immune privilege","volume":"162","author":"Phillips","year":"1999","journal-title":"J Immunol"},{"key":"10.1080\/00313020400011268_bib0035","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0014-5793(98)00409-8","article-title":"APO2 ligand a novel lethal weapon against malignant glioma?","volume":"427","author":"Rieger","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1080\/00313020400011268_bib0040","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.4049\/jimmunol.161.5.2195","article-title":"TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells","volume":"161","author":"Thomas","year":"1998","journal-title":"J Immunol"},{"key":"10.1080\/00313020400011268_bib0045","first-page":"2747","article-title":"Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma","volume":"59","author":"Zhang","year":"1999","journal-title":"Cancer Res"},{"key":"10.1080\/00313020400011268_bib0050","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0014-5793(00)02042-1","article-title":"Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types","volume":"482","author":"Zhang","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1080\/00313020400011268_bib0055","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nrc821","article-title":"Targeting death and decoy receptors of the tumournecrosis factor superfamily","volume":"2","author":"Ashkenazi","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1080\/00313020400011268_bib0060","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1172\/JCI6926","article-title":"Safety and antitumour activity of recombinant soluble Apo2 ligand","volume":"104","author":"Ashkenazi","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1080\/00313020400011268_bib0065","first-page":"6153","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand's antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT-11","volume":"59","author":"Gliniak","year":"1999","journal-title":"Cancer Res"},{"key":"10.1080\/00313020400011268_bib0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/5517","article-title":"Tumoricidal activity of tumour necrosis factor-related apoptosis-inducing ligand in vivo","volume":"5","author":"Walczak","year":"1999","journal-title":"Nat Med"},{"key":"10.1080\/00313020400011268_bib0075","first-page":"768","article-title":"How TRAIL kills cancer cells but not normal cells","volume":"277","author":"Gura","year":"1997","journal-title":"Cancer Res"},{"key":"10.1080\/00313020400011268_bib0080","first-page":"243","article-title":"Immunologically-mediated tumour cell apoptosis: the role of TRAIL in T-cell and cytokine-mediated responses to melanoma","volume":"10","author":"Nguyen","year":"2000","journal-title":"Forum"},{"key":"10.1080\/00313020400011268_bib0085","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.4049\/jimmunol.162.5.2639","article-title":"Involvement of TNF-related apoptosis-inducing ligand in human T cell-mediated cytotoxicity","volume":"162","author":"Kayagaki","year":"1999","journal-title":"J Immunol"},{"key":"10.1080\/00313020400011268_bib0090","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/83416","article-title":"Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells","volume":"7","author":"Takeda","year":"2001","journal-title":"Nat Med"},{"key":"10.1080\/00313020400011268_bib0095","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1084\/jem.190.8.1155","article-title":"Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)","volume":"190","author":"Fanger","year":"1999","journal-title":"J Exp Med"},{"key":"10.1080\/00313020400011268_bib00100","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1084\/jem.189.8.1343","article-title":"Monocyte-mediated tumoricidal activity via the tumor necrosis factor related cytokine, TRAIL","volume":"189","author":"Griffith","year":"1999","journal-title":"J Exp Med"},{"key":"10.1080\/00313020400011268_bib00105","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4049\/jimmunol.171.1.212","article-title":"Plasmacytoid dendritic cell-derived IFN-alpha induces TNF-related apoptosis-inducing ligand\/Apo-2L-mediated antitumor activity by human monocytes following CpG oligodeoxynucleotide stimulation","volume":"171","author":"Kemp","year":"2003","journal-title":"J Immunol"},{"key":"10.1080\/00313020400011268_bib00110","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1084\/jem.189.9.1451","article-title":"Type I (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs","volume":"189","author":"Kayagaki","year":"1999","journal-title":"J Exp Med"},{"key":"10.1080\/00313020400011268_bib00115","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1750-3639.1997.tb00889.x","article-title":"Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors","volume":"7","author":"Gratas","year":"1997","journal-title":"Brain Pathol"},{"key":"10.1080\/00313020400011268_bib00120","first-page":"1007","article-title":"Human lung carcinoma express Fas Ligand","volume":"57","author":"Niehans","year":"1997","journal-title":"Cancer Res"},{"key":"10.1080\/00313020400011268_bib00125","doi-asserted-by":"crossref","first-page":"6420","DOI":"10.1073\/pnas.94.12.6420","article-title":"Expression of Fas ligand in liver metastases of human colonic adenocarcinomas","volume":"94","author":"Shiraki","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1080\/00313020400011268_bib00130","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1126\/science.274.5291.1363","article-title":"Melanoma cell expression of Fas (Apo-1\/CD95) ligand: implications for tumor immune escape","volume":"274","author":"Hahne","year":"1996","journal-title":"Science"},{"key":"10.1080\/00313020400011268_bib00135","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1084\/jem.184.3.1075","article-title":"The Fas counterattack: Fas-mediated T Cell killing by colon cancer cells expressing Fas ligand","volume":"184","author":"O'Connell","year":"1996","journal-title":"J Exp Med"},{"key":"10.1080\/00313020400011268_bib00140","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.4049\/jimmunol.163.9.4886","article-title":"A 'stealth effect': Adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions","volume":"163","author":"Giovarelli","year":"1999","journal-title":"J Immunol"},{"key":"10.1080\/00313020400011268_bib00145","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/cncr.11196","article-title":"Tumor mitotic rate is more powerful prognostic indicator than ulceration in patients with primary cutaneous melanomas: an analysis of 3661 patients from a single center","volume":"97","author":"Azzola","year":"2003","journal-title":"Cancer"},{"key":"10.1080\/00313020400011268_bib00150","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.4049\/jimmunol.167.6.3164","article-title":"Disruption of NF-kappaB signaling reveals a novel role for NF-kappaB in the regulation of TNF-related apoptosis-inducing ligand expression","volume":"167","author":"Beatu","year":"2001","journal-title":"J Immunol"},{"key":"10.1080\/00313020400011268_bib00155","first-page":"7335","article-title":"Constitutive activation of Akt\/protein kinase B in melanoma leads to regulation of nuclear factor kappaB and tumor progression","volume":"62","author":"Dhawan","year":"2002","journal-title":"Cancer Res"},{"key":"10.1080\/00313020400011268_bib00160","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1038\/sj.onc.1206520","article-title":"TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-kappaB","volume":"22","author":"Ehrhardt","year":"2003","journal-title":"Oncogene"},{"key":"10.1080\/00313020400011268_bib00165","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.4049\/jimmunol.165.5.2886","article-title":"Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand\/Apo-2 ligand gene induces tumor apoptosis","volume":"165","author":"Griffith","year":"2000","journal-title":"J Immunol"},{"key":"10.1080\/00313020400011268_bib00170","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/ijc.10539","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand supports growth of mouse mastocytoma tumors by killing tumor-infiltrating macrophages","volume":"100","author":"Strebel","year":"2002","journal-title":"Int J Cancer"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003130251634137X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003130251634137X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T02:46:41Z","timestamp":1682995601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003130251634137X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S003130251634137X"],"URL":"https:\/\/doi.org\/10.1080\/00313020400011268","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}